Publicaciones en las que colabora con MARTA HERREROS VILLANUEVA (60)

2022

  1. Circulating tumor DNA tracking in patients with pancreatic cancer using next-generation sequencing

    Gastroenterologia y Hepatologia, Vol. 45, Núm. 8, pp. 637-644

2020

  1. CA19-9 capability as predictor of pancreatic cancer resectability in a Spanish cohort

    Molecular Biology Reports, Vol. 47, Núm. 3, pp. 1583-1588

  2. Validation of miR-1228-3p as housekeeping for microRNA analysis in liquid biopsies from colorectal cancer patients

    Biomolecules, Vol. 10, Núm. 1

2019

  1. Correction: Plasma MicroRNA Signature Validation for Early Detection of Colorectal Cancer (Clinical and Translational Gastroenterology, (2019) 10, e-00031, 10.14309/ctg.0000000000000003)

    Clinical and Translational Gastroenterology

  2. Endometriosis-associated ovarian cancer: What have we learned so far?

    Clinica Chimica Acta, Vol. 493, pp. 63-72

  3. Plasma MicroRNA Signature Validation for Early Detection of Colorectal Cancer

    Clinical and translational gastroenterology, Vol. 10, Núm. 1, pp. e00003

2018

  1. HIV epidemiology in uganda: Survey based on age, gender, number of sexual partners and frequency of testing

    African Health Sciences, Vol. 18, Núm. 3, pp. 523-530

  2. Plasma miRNAs signature validation for early detection of colorectal cancer

    Annals of oncology : official journal of the European Society for Medical Oncology, Vol. 29, pp. v106

2017

  1. Antimicrobial susceptibility testing before first-line treatment for Helicobacter pylori infection in patients with dual or triple antibiotic resistance

    World Journal of Gastroenterology, Vol. 23, Núm. 18, pp. 3367-3373

  2. Dealing with pancreatic cancer in two different ways

    Clinica Chimica Acta

  3. Pancreatic cancer in lynch syndrome patients

    Journal of Cancer, Vol. 8, Núm. 18, pp. 3667-3674

  4. Triple synchronous gastric tumors: A rare combination diffuse adenocarcinoma, B-cell MALT lymphoma and large cell neuroendocrine carcinoma

    Gastroenterologia y Hepatologia, Vol. 40, Núm. 10, pp. 675-677

2016

  1. Glypican-1 in exosomes as biomarker for early detection of pancreatic cancer

    Annals of Translational Medicine

  2. Immunotherapy in colorectal cancer: What have we learned so far?

    Clinica Chimica Acta, Vol. 460, pp. 78-87

  3. Influence of dopaminergic system genetic variation and lifestyle factors on excessive alcohol consumption

    Alcohol and Alcoholism, Vol. 51, Núm. 3, pp. 258-267

  4. Non-invasive biomarkers in pancreatic cancer diagnosis: What we need versus what we have

    Annals of Translational Medicine, Vol. 4, Núm. 7

  5. Targeted next-generation sequencing for molecular diagnosis of endometriosis-associated ovarian cancer

    Journal of Molecular Medicine, Vol. 94, Núm. 7, pp. 835-847

  6. p-21 activated kinase 4 (PAK4) role in pancreatic cancer stem cells

    Translational Cancer Research

2015

  1. Molecular characterization of oral squamous cell carcinoma using targeted next-generation sequencing

    Oral Diseases, Vol. 21, Núm. 7, pp. 872-878

  2. Pharmacogenomic biomarkers for colorectal cancer treatment

    Cancer Treatment Communications